B

Bio-Rad Laboratories
D

BIO/B

228.700
USD
0.70
(0.31%)
مغلق
حجم التداول
0
الربح لكل سهم
8
العائد الربحي
-
P/E
-3
حجم السوق
6,223,522,992
أصول ذات صلة
B
BIO
-1.290
(-0.56%)
230.630 USD
DGX
DGX
-3.120
(-1.71%)
178.970 USD
ILMN
ILMN
-0.770
(-0.85%)
89.510 USD
Q
QGEN
-0.875
(-1.84%)
46.570 USD
TMO
TMO
-14.95
(-3.69%)
390.27 USD
المزيد
الأخبار المقالات

العنوان: Bio/Rad Laboratories

القطاع: Healthcare
الصناعة: Medical Devices
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.